ArticleOncotarget2017

Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma.

Lijuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.